Infectious Disease Assay Development

About Systaaq Diagnostic Products

Systaaq is a private, commercial-stage diagnostics company focused on providing molecular testing solutions for infectious diseases. Its core offerings include real-time PCR kits for pathogens like HIV, HBV, HCV, and SARS-CoV-2, alongside nucleic acid extraction products and master mixes. The company leverages a flexible development model, claiming the ability to create new tests in under 30 days, and serves medium-to-high throughput testing laboratories globally. Systaaq emphasizes customer-focused, custom solutions and technical support, positioning itself as a nimble player in the molecular diagnostics market.

About CD Diagnostics

CD Diagnostics is a private, commercial-stage company that has been operating since 2003, generating revenue through its diagnostic services. Its core business involves providing clinical testing and developing proprietary assays, with a stated focus on infectious diseases. As a smaller, specialized player, the company likely competes by offering targeted diagnostic solutions, though detailed information on its technology and market position is limited without further public disclosure.

Therapeutic Areas